Paper Details

  1. Home
  2. Paper Details

Treatment of locally advanced pancreatic carcinoma in Sweden. A health economic comparison of palliative treatment with best supportive care versus palliative treatment with gemcitabine in combination with best supportive care.

Author: Ragnarson-TennvallG, WilkingN

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study performed a health economic evaluation of palliative treatment with gemcitabine versus standard palliative treatment in patients with locally advanced pancreatic carcinoma, given the short survival of patients with this diagnosis.
Paper Details　
Original Abstract of the Article :
Patients with pancreatic cancer have only short survival after diagnosis, irrespective of treatment. The aim of this study was to perform a health economic evaluation of present standard treatment (in most cases, palliative treatment in combination with best supportive care) versus palliative treatm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2165/00019053-199915040-00005

データ提供：米国国立医学図書館（NLM）

Palliative Care: Navigating the Desert of Pancreatic Cancer

The field of Pancreatic Cancer is a challenging desert, where researchers seek to find effective treatments and improve outcomes for patients with this aggressive disease. This study, published in the field of Oncology, investigates the cost-effectiveness of palliative treatment with gemcitabine compared to palliative treatment with best supportive care for patients with locally advanced pancreatic carcinoma. The researchers aimed to provide a health economic evaluation of these two treatment approaches.

Palliative Care: Balancing Cost and Benefit

The study's findings suggest that palliative treatment with gemcitabine, while more costly, may offer a longer survival time and potentially improved quality of life for patients with locally advanced pancreatic carcinoma. This finding underscores the need to balance the cost-effectiveness of treatments with the potential benefits for patients, considering factors such as survival time, quality of life, and individual patient preferences.

Navigating the Desert of Palliative Care Decisions

The study's findings highlight the complexity of making palliative care decisions for patients with pancreatic cancer. The choice between different treatment options should be made on an individual basis, considering the patient's overall health status, their goals of care, and the potential benefits and risks associated with each treatment approach. Open and honest communication between patient and healthcare providers is essential for making informed decisions.

Dr. Camel's Conclusion

This study, like a compass guiding us through the desert of pancreatic cancer treatment, emphasizes the need to carefully consider the cost-effectiveness of palliative care options. The researchers' findings provide valuable insights into the potential benefits and limitations of different treatment approaches, allowing healthcare providers and patients to make informed decisions about end-of-life care.

Date :
  1. Date Completed 1999-07-16
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

10537956

DOI: Digital Object Identifier

10.2165/00019053-199915040-00005

Related Literature

Article Analysis
・Effective treatment of pancreatic cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.